Editorial: Dynamic Biomarkers of Response to Anti-Immune Checkpoint Inhibitors in Cancer

Front Immunol. 2021 Oct 21:12:781872. doi: 10.3389/fimmu.2021.781872. eCollection 2021.
No abstract available

Keywords: dynamic biomarkers; immune checkpoint inhibitors (ICI); irAEs; programmed cell death ligand 1 (PD-L1); programmed cell death protein 1 (PD1).

Publication types

  • Editorial
  • Introductory Journal Article
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Biomarkers, Tumor*
  • Humans
  • Immune Checkpoint Inhibitors / pharmacology
  • Immune Checkpoint Inhibitors / therapeutic use*
  • Immune Checkpoint Proteins* / genetics
  • Immune Checkpoint Proteins* / metabolism
  • Molecular Targeted Therapy* / adverse effects
  • Molecular Targeted Therapy* / methods
  • Neoplasms / diagnosis
  • Neoplasms / drug therapy*
  • Neoplasms / etiology*
  • Neoplasms / mortality
  • Prognosis
  • Treatment Outcome

Substances

  • Biomarkers, Tumor
  • Immune Checkpoint Inhibitors
  • Immune Checkpoint Proteins